Oral Debio1143 (AT406), an Antagonist of Inhibitor of Apoptosis Proteins, Combined With Daunorubicin and Cytarabine in Patients With Poor-Risk Acute Myeloid Leukemia—Results of a Phase I Dose-Escalation Study

Autor: DiPersio, John F., Erba, Harry P., Larson, Richard A., Luger, Selina M., Tallman, Martin S., Brill, Jeffrey M., Vuagniaux, Gregoire, Rouits, Elisabeth, Sorensen, J. Mel, Zanna, Claudio
Zdroj: In Clinical Lymphoma Myeloma and Leukemia July 2015 15(7):443-449
Databáze: ScienceDirect